6 reports

  • RESPIRATORY DISORDERS THERAPEUTICS MARKET, GLOBAL, LICENSING DEALS VALUED ABOVE $100M, 2006-2017
  • Strategic Consolidations

HUNDREDS OF PHARMACEUTICAL SPECIFIC NEWS SOURCES ARE MONITORED ON A DAILY BASIS.

  • Pharmaceutical
  • Respiratory Disease
  • Respiratory Treatment
  • Therapy
  • Cytokinetics, Inc.
  • ASTELLAS PHARMA EXPANDS LICENSING AGREEMENT WITH CYTOKINETICS
  • Cytokinetics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017
  • Dementia
  • Pharmaceutical
  • United States
  • Corporate Finance
  • Cytokinetics, Inc.
  • NUMBER OF PRODUCTS UNDER DEVELOPMENT BY COMPANIES, H2 2017
  • PRODUCTS UNDER DEVELOPMENT BY COMPANIES

In collaboration with Astellas Pharma Inc.

  • Neurological Disorder
  • Pharmaceutical
  • Therapy
  • United States
  • Cytokinetics, Inc.
  • PRODUCTS UNDER DEVELOPMENT BY COMPANIES, H1 2017 (CONTD..1), H1 2017
  • NUMBER OF PRODUCTS UNDER DEVELOPMENT BY COMPANIES, H1 2017

Paratek Pharmaceuticals Inc (Paratek Pharmaceuticals), formerly Transcept Pharmaceuticals, Inc., discovers, develops and commercializes antibiotics for infectious diseases.

  • Neurological Disorder
  • Pharmaceutical
  • United States
  • Product Initiative
  • Cytokinetics, Inc.
  • PROMINENT SPONSORS
  • CLINICAL TRIALS BY SPONSOR TYPE

GDCT ID is the unique ID of GlobalData' s Pharma Intelligence Center clinical trial database updates, etc.

  • Cardiology
  • Cardiovascular Disease
  • Clinical Trial
  • Pharmaceutical
  • Cytokinetics, Inc.
  • TOP DEALS IN (2012 -YTD2016)
  • PARTNERSHIP - DEAL REPORTS

Astellas Pharma, Inc.

  • Pharmaceutical
  • United Kingdom
  • United States
  • Corporate Finance
  • Cytokinetics, Inc.